SlideShare a Scribd company logo
1 of 25
Download to read offline
D
r.O
.J.de
Vries
Valpreventie
Introduction
§  30 % of all people 65 and older fall ≥ once/year
§  15 % falls ≥ twice/year.
§  10% leads to injuries
§  5 % leads to fractures: 1-2% hip fracture
§  Big impact on quality of life.
§  24% of 55 yr and over dies within a year following a hip fracture
D
r.O
.J.de
Vries
Valpreventie
D
r.O
.J.de
Vries
Valpreventie
Increased fall risk
§  Risk factors:
§  Age
§  Dementia
§  Diminished visual acuity
§  Low body weight
§  Gait disorder
§  Prior fall
§  ≥ 4 generic drugs
§  Psychofarmacologicaly active drugs
§  Orthostatic hypotension
§  Interaction intrinsic/extrinsic factors
D
r.O
.J.de
Vries
Valpreventie
Increased fall risk
§  Risk factors:
§  Age
§  Dementia
§  Diminished visual acuity
§  Low body weight
§  Gait disorder
§  Prior fall
§  ≥ 4 generic drugs
§  Psychofarmacologicaly active drugs
§  Orthostatic hypotension
§  Interaction intrinsic/extrinsic factors
D
r.O
.J.de
Vries
Valpreventie
Longitudinal Aging Study Amsterdam
§  1992: inclusion of 3107 participants 65 yr and
older in and around Zwolle, Oss and
Amsterdam
§  1995/1996: medical interview of 1509
participants
§  Fall registration during 3 years
D
r.O
.J.de
Vries
Valpreventie
Benzodiazepines
§  Screening-instrument (STOPP):
§  Especially avoid long-acting
benzodiazepines (half-life ≥ 24h) because
of increased fall risk.
D
r.O
.J.de
Vries
Valpreventie
STOPP criteria
Gallagher et al, Age and Ageing 2008; 37: 673-9
D
r.O
.J.de
Vries
Valpreventie
STOPP criteria
Gallagher et al, Age and Ageing 2008; 37: 673-9
D
r.O
.J.de
Vries
Valpreventie
Benzodiazepines
§  Screening-instrument (STOPP):
§  Especially avoid long-acting
benzodiazepines (half-life ≥ 24h) because
of increased fall risk.
§  Hypothese:
§  Short-acting benzodiazepines (T1/2 ≤ 10h)
are also associated with an increased fall
risk.
D
r.O
.J.de
Vries
Valpreventie
Benzodiazepines
§  Screening-instrument (STOPP):
§  Especially avoid long-acting
benzodiazepines (half-life ≥ 24h) because
of increased fall risk.
§  Hypothese:
§  Short-acting benzodiazepines (T1/2 ≤ 10h)
are also associated with an increased fall
risk.
§  Result:
§  Short-acting benzodiazepines are
associated with an increased fall risk.
De Vries, O.J. et al. Age and Ageing 2013;0:1-7
D
r.O
.J.de
Vries
Valpreventie
Antacids
§  Literature:
§  Protonpump inhibitor use is associated with increased fracture
incidence.
§  Hypothesis:
§  PPI use is associated with more falls and fractures than other
antacids
§  Results:
§  PPI use is not associated with increased fall incidence
§  H2-blocker is associated with increased fall incidence.
D
r.O
.J.de
Vries
Valpreventie
Frailty
§  Literature:
§  Physical frailty is associated with increased fall risk
§  Hypothesis:
§  Frailty according to LASA is also associated with increased fall
risk.
§  Result:
§  Frailty according to LASA is associated with increased fall risk.
§  Prior falls are at least as predictive.
De Vries O.J. et al. Osteoporosis International 2013; 24:2397-403
D
r.O
.J.de
Vries
Valpreventie
Robinovitch S.N. et al. Lancet 2013;381:47-54
D
r.O
.J.de
Vries
Valpreventie
Video capture of the circumstances of falls in elderly
people residing in long-term care: an observational study.
§  227 falls of 130 persons
(mean age 78 yr, SD 10)
§  Activities during fall:
§  Walking forward 24%
§  Standing 13%
§  Sitting down 12%
§  Start walking 9%
§  Rising from a chair 9%
§  Cause of fall:
§  Weight shifting 41%
§  Trip or stumble 21%
§  Hit or bump 11%
§  Loss of support 11%
§  Collapse 11%
§  Slipping 3%
Robinovitch et al. Lancet 2013;381:47-54.
D
r.O
.J.de
Vries
Valpreventie
http://www.thelancet/cms/attachment/2024445407/2044188965/mmc1.mp4
D
r.O
.J.de
Vries
Valpreventie
CBO guideline (2004)
“Prevention of falls in older persons”
D
r.O
.J.de
Vries
Valpreventie
The CBO fall guideline recommends:
§  Medication evaluation
§  Balance and strength training
§  Restore visual acuity
§  Safety in and around home
§  Estimate fracture risk
§  Consider evaluation of heart rhythm disorders
§  Possibly the highest risk reduction can be achieved in
high risk older persons.
D
r.O
.J.de
Vries
Valpreventie
Multifactorial fall prevention study
§  Hypothesis:
§  Multifactorial analysis and intervention in older
persons with increased fall risk leads to prevention of
new falls.
§  Method:
§  217 older persons in and around Amsterdam
§  Recent fall (ED or general practitioner)
§  Intervention and control group(106 vs 111)
§  1 year fall follow-up (calendar)
§  After 1 year measurement of QoL, mobility and
mood.
D
r.O
.J.de
Vries
Valpreventie
Multifactorial fall prevention study
§  Results:
§  No difference between intervention and control group in time to
first fall.
§  In both groups decrease of the number of falls.
§  No differences in secondary outcomes apart from mortality.
§  Discussion:
§  A lot of interventions in the control group.
§  Most potential participants refused: selection of the most
motivated.
§  The type of physical therapy possibly led to increased fall risk.
D
r.O
.J.de
Vries
Valpreventie
Medication reduction fall prevention
§  Hypothesis:
§  Stopping or reducing fall-risk-increasing drugs in high
risk older persons leads to prevention of new falls.
§  Method:
§  612 older persons in and around Rotterdam and
Amsterdam
§  Recent fall (ED)
§  Intervention and control group (319 vs 293)
§  1 year registration of falls, GP and ED visits.
§  After 1 year measurement of QoL.
D
r.O
.J.de
Vries
Valpreventie
Medication reduction fall prevention
§  Results:
§  No difference in time to 1st or 2nd fall nor in number of falls.
§  40% of the FRIDs were necessary.
§  36% of the medication reduction interventions failed.
§  Discussion:
§  ≥50% of the FRIDs were not discontinued; compliance,
dependence, necessity?
§  Possibly better effect with long-term physician-patient relation.
D
r.O
.J.de
Vries
Valpreventie
Meta-analysis
§  Gillespie LD, et al. Interventions for preventing falls in
older people living in the community. Cochrane
Database Syst Rev. 2012
§  159 trials with 79,193 community dwelling participants
§  Results:
§  Physical therapy or tai-chi: reduces both fall risk
and fall rate.
§  Multifactorial fall prevention: reduces only fall rate.
D
r.O
.J.de
Vries
Valpreventie
Future
§  Studies of the relation between risk factors and
effectivity of different interventions.
§  Studies of more effective fall prevention: medication,
physical therapy, reduction of fear of falls, etc.
§  Clinically relevant and irrespective of dogmas
D
r.O
.J.de
Vries
D
r.O
.J.de
Vries

More Related Content

What's hot (9)

Debate advances in hf ofili
Debate advances in hf ofiliDebate advances in hf ofili
Debate advances in hf ofili
 
Debate evidence bases guideline handler
Debate evidence bases guideline handlerDebate evidence bases guideline handler
Debate evidence bases guideline handler
 
Jnc 8 full
Jnc 8 fullJnc 8 full
Jnc 8 full
 
Lithium Antisocial Behavior
Lithium Antisocial BehaviorLithium Antisocial Behavior
Lithium Antisocial Behavior
 
An interdisciplinary approach to dialysis decision making in the ckd patient ...
An interdisciplinary approach to dialysis decision making in the ckd patient ...An interdisciplinary approach to dialysis decision making in the ckd patient ...
An interdisciplinary approach to dialysis decision making in the ckd patient ...
 
Nutritional and metabolic considerations in elderly dialysis patients
Nutritional and metabolic considerations in elderly dialysis patientsNutritional and metabolic considerations in elderly dialysis patients
Nutritional and metabolic considerations in elderly dialysis patients
 
Myths in Nephrology 1
Myths in Nephrology 1Myths in Nephrology 1
Myths in Nephrology 1
 
Myths and facts in Nephrology, 2016
Myths and facts in Nephrology, 2016Myths and facts in Nephrology, 2016
Myths and facts in Nephrology, 2016
 
Lipid guidelines
Lipid guidelinesLipid guidelines
Lipid guidelines
 

Viewers also liked

dịch vụ làm video quảng cáo chất lượng cao
dịch vụ làm video quảng cáo chất lượng caodịch vụ làm video quảng cáo chất lượng cao
dịch vụ làm video quảng cáo chất lượng cao
andrew368
 
GLAND & TERMINATION
GLAND & TERMINATIONGLAND & TERMINATION
GLAND & TERMINATION
Taner HAZAR
 
chỗ nào làm phim quảng cáo tốt nhất
chỗ nào làm phim quảng cáo tốt nhấtchỗ nào làm phim quảng cáo tốt nhất
chỗ nào làm phim quảng cáo tốt nhất
dominick604
 
công ty thiết kế video quảng cáo độc đáo
công ty thiết kế video quảng cáo độc đáocông ty thiết kế video quảng cáo độc đáo
công ty thiết kế video quảng cáo độc đáo
amalia706
 
Mistakes_Expungement_March 20_2016
Mistakes_Expungement_March 20_2016Mistakes_Expungement_March 20_2016
Mistakes_Expungement_March 20_2016
Carole Renninger
 
αγαπητοι ακροατες
αγαπητοι ακροατεςαγαπητοι ακροατες
αγαπητοι ακροατες
roga agla
 

Viewers also liked (20)

Ancon wall ties
Ancon wall tiesAncon wall ties
Ancon wall ties
 
Epic research weekly agri report 04th to 8th may 2015
Epic research weekly agri report  04th to 8th  may  2015Epic research weekly agri report  04th to 8th  may  2015
Epic research weekly agri report 04th to 8th may 2015
 
Cách làm hồ sơ vay tín chấp giải ngân nhanh nhất
Cách làm hồ sơ vay tín chấp giải ngân nhanh nhấtCách làm hồ sơ vay tín chấp giải ngân nhanh nhất
Cách làm hồ sơ vay tín chấp giải ngân nhanh nhất
 
dịch vụ làm video quảng cáo chất lượng cao
dịch vụ làm video quảng cáo chất lượng caodịch vụ làm video quảng cáo chất lượng cao
dịch vụ làm video quảng cáo chất lượng cao
 
EGGS TV. Constructor of television
EGGS TV. Constructor of televisionEGGS TV. Constructor of television
EGGS TV. Constructor of television
 
GLAND & TERMINATION
GLAND & TERMINATIONGLAND & TERMINATION
GLAND & TERMINATION
 
Tiết 2 3
Tiết 2   3Tiết 2   3
Tiết 2 3
 
chỗ nào làm phim quảng cáo tốt nhất
chỗ nào làm phim quảng cáo tốt nhấtchỗ nào làm phim quảng cáo tốt nhất
chỗ nào làm phim quảng cáo tốt nhất
 
công ty thiết kế video quảng cáo độc đáo
công ty thiết kế video quảng cáo độc đáocông ty thiết kế video quảng cáo độc đáo
công ty thiết kế video quảng cáo độc đáo
 
Покупка онлайн
Покупка онлайнПокупка онлайн
Покупка онлайн
 
Angular light introduction
Angular light introductionAngular light introduction
Angular light introduction
 
MixologyRules
MixologyRulesMixologyRules
MixologyRules
 
Ibstock special bricks
Ibstock special bricksIbstock special bricks
Ibstock special bricks
 
Q-Trade Bootcamp 2015: Quantitative, Algorithmic Trading & HFT
 Q-Trade Bootcamp 2015: Quantitative, Algorithmic Trading & HFT Q-Trade Bootcamp 2015: Quantitative, Algorithmic Trading & HFT
Q-Trade Bootcamp 2015: Quantitative, Algorithmic Trading & HFT
 
How To Be An Even Better Superhero
How To Be An Even Better SuperheroHow To Be An Even Better Superhero
How To Be An Even Better Superhero
 
Claiming your territory
Claiming your territoryClaiming your territory
Claiming your territory
 
Mistakes_Expungement_March 20_2016
Mistakes_Expungement_March 20_2016Mistakes_Expungement_March 20_2016
Mistakes_Expungement_March 20_2016
 
Silent auction sign
Silent auction signSilent auction sign
Silent auction sign
 
αγαπητοι ακροατες
αγαπητοι ακροατεςαγαπητοι ακροατες
αγαπητοι ακροατες
 
COL letter of rec
COL letter of recCOL letter of rec
COL letter of rec
 

Similar to Seminair 28-04-2015 Dr. O.J. de Vries

Amy_Herf_10_2014_Focus_Article_pp10
Amy_Herf_10_2014_Focus_Article_pp10Amy_Herf_10_2014_Focus_Article_pp10
Amy_Herf_10_2014_Focus_Article_pp10
Amy Lynn Herf
 
Fall prevention in elderly population
Fall prevention in elderly populationFall prevention in elderly population
Fall prevention in elderly population
Risho1012
 
Preventing Patient Falls in Acute Care Hospitals
Preventing Patient Falls in Acute Care HospitalsPreventing Patient Falls in Acute Care Hospitals
Preventing Patient Falls in Acute Care Hospitals
Joe Tomsic
 

Similar to Seminair 28-04-2015 Dr. O.J. de Vries (20)

ILS Position Statement: Seizure Disorders in Lifesaving and Lifeguarding
ILS Position Statement: Seizure Disorders in Lifesaving and LifeguardingILS Position Statement: Seizure Disorders in Lifesaving and Lifeguarding
ILS Position Statement: Seizure Disorders in Lifesaving and Lifeguarding
 
Down Syndrome
Down SyndromeDown Syndrome
Down Syndrome
 
Amy_Herf_10_2014_Focus_Article_pp10
Amy_Herf_10_2014_Focus_Article_pp10Amy_Herf_10_2014_Focus_Article_pp10
Amy_Herf_10_2014_Focus_Article_pp10
 
Fall prevention in elderly population
Fall prevention in elderly populationFall prevention in elderly population
Fall prevention in elderly population
 
Comparative study to assess the Effect of Standing Position & Sitting Positio...
Comparative study to assess the Effect of Standing Position & Sitting Positio...Comparative study to assess the Effect of Standing Position & Sitting Positio...
Comparative study to assess the Effect of Standing Position & Sitting Positio...
 
Yoga for preventing fall among elderly people
Yoga for preventing fall among elderly peopleYoga for preventing fall among elderly people
Yoga for preventing fall among elderly people
 
Symptoms checker
Symptoms checkerSymptoms checker
Symptoms checker
 
Esrd in elderly patients 2019 latest
Esrd in elderly patients 2019 latestEsrd in elderly patients 2019 latest
Esrd in elderly patients 2019 latest
 
Cardiovascular problems in Elderly
Cardiovascular problems in ElderlyCardiovascular problems in Elderly
Cardiovascular problems in Elderly
 
Orthogeriatrics
OrthogeriatricsOrthogeriatrics
Orthogeriatrics
 
Vitamin D and Fall prevention
Vitamin D and Fall preventionVitamin D and Fall prevention
Vitamin D and Fall prevention
 
Bone Health, Falls Prevention and Falls Reduction Strategies - AIGNA Mastercl...
Bone Health, Falls Prevention and Falls Reduction Strategies - AIGNA Mastercl...Bone Health, Falls Prevention and Falls Reduction Strategies - AIGNA Mastercl...
Bone Health, Falls Prevention and Falls Reduction Strategies - AIGNA Mastercl...
 
Seshadri Sundararajan.Adithya
Seshadri Sundararajan.AdithyaSeshadri Sundararajan.Adithya
Seshadri Sundararajan.Adithya
 
Hd o dp en ancianos fragiles
Hd o dp en ancianos fragilesHd o dp en ancianos fragiles
Hd o dp en ancianos fragiles
 
White paper on hcq 2020.2
White paper on hcq 2020.2White paper on hcq 2020.2
White paper on hcq 2020.2
 
Daniel Edmundowicz: Atherosclerosis Imaging
Daniel Edmundowicz: Atherosclerosis ImagingDaniel Edmundowicz: Atherosclerosis Imaging
Daniel Edmundowicz: Atherosclerosis Imaging
 
Body dysmorphic disorder in adult orthodontic patients
Body dysmorphic disorder in adult orthodontic patientsBody dysmorphic disorder in adult orthodontic patients
Body dysmorphic disorder in adult orthodontic patients
 
IMEs An Independent Medical Examiner's perspective
IMEs An Independent Medical Examiner's perspectiveIMEs An Independent Medical Examiner's perspective
IMEs An Independent Medical Examiner's perspective
 
Preventing Patient Falls in Acute Care Hospitals
Preventing Patient Falls in Acute Care HospitalsPreventing Patient Falls in Acute Care Hospitals
Preventing Patient Falls in Acute Care Hospitals
 
A Guide to Reducing Falls in the PACE Population
A Guide to Reducing Falls in the PACE PopulationA Guide to Reducing Falls in the PACE Population
A Guide to Reducing Falls in the PACE Population
 

More from Stichting Interdisciplinaire Werkgroep Osteoporose

More from Stichting Interdisciplinaire Werkgroep Osteoporose (20)

IWO Meeting 1 November 2023 - Stopping with Denosumab and Romosozumab, basic ...
IWO Meeting 1 November 2023 - Stopping with Denosumab and Romosozumab, basic ...IWO Meeting 1 November 2023 - Stopping with Denosumab and Romosozumab, basic ...
IWO Meeting 1 November 2023 - Stopping with Denosumab and Romosozumab, basic ...
 
IWO Meeting 1 November 2023 - De concept versie van de nieuwe NHG-standaard O...
IWO Meeting 1 November 2023 - De concept versie van de nieuwe NHG-standaard O...IWO Meeting 1 November 2023 - De concept versie van de nieuwe NHG-standaard O...
IWO Meeting 1 November 2023 - De concept versie van de nieuwe NHG-standaard O...
 
IWO Meeting 1 November 2023 - Pitfalls DXA en VFA door Prof. dr. R. Slart (Gr...
IWO Meeting 1 November 2023 - Pitfalls DXA en VFA door Prof. dr. R. Slart (Gr...IWO Meeting 1 November 2023 - Pitfalls DXA en VFA door Prof. dr. R. Slart (Gr...
IWO Meeting 1 November 2023 - Pitfalls DXA en VFA door Prof. dr. R. Slart (Gr...
 
IWO Meeting 19 April 2023 - Reflectie op en implementatie van de richtlijn o...
IWO Meeting 19 April 2023 -  Reflectie op en implementatie van de richtlijn o...IWO Meeting 19 April 2023 -  Reflectie op en implementatie van de richtlijn o...
IWO Meeting 19 April 2023 - Reflectie op en implementatie van de richtlijn o...
 
IWO Meeting 19 April 2023 - Romosozumab anno 2023 door Prof. Dr. W.F. Lems
IWO Meeting 19 April 2023 -  Romosozumab anno 2023 door Prof. Dr. W.F. LemsIWO Meeting 19 April 2023 -  Romosozumab anno 2023 door Prof. Dr. W.F. Lems
IWO Meeting 19 April 2023 - Romosozumab anno 2023 door Prof. Dr. W.F. Lems
 
IWO Meeting 19 April 2023 - Wanneer zoledronaat na een heupfractuur? door Dr....
IWO Meeting 19 April 2023 - Wanneer zoledronaat na een heupfractuur? door Dr....IWO Meeting 19 April 2023 - Wanneer zoledronaat na een heupfractuur? door Dr....
IWO Meeting 19 April 2023 - Wanneer zoledronaat na een heupfractuur? door Dr....
 
IWO Meeting 19 April 2023 - Chronische Hypofosfatemie door Prof. Dr. M.C. Zil...
IWO Meeting 19 April 2023 - Chronische Hypofosfatemie door Prof. Dr. M.C. Zil...IWO Meeting 19 April 2023 - Chronische Hypofosfatemie door Prof. Dr. M.C. Zil...
IWO Meeting 19 April 2023 - Chronische Hypofosfatemie door Prof. Dr. M.C. Zil...
 
IWO Meeting 16 November 2022 - ONJ review van ECTS (osteonecrose van de kaak)
IWO Meeting 16 November 2022 - ONJ review van ECTS (osteonecrose van de kaak)IWO Meeting 16 November 2022 - ONJ review van ECTS (osteonecrose van de kaak)
IWO Meeting 16 November 2022 - ONJ review van ECTS (osteonecrose van de kaak)
 
IWO Meeting 16 November 2022 - Tumor-induced osteomalacia: a systematic clini...
IWO Meeting 16 November 2022 - Tumor-induced osteomalacia: a systematic clini...IWO Meeting 16 November 2022 - Tumor-induced osteomalacia: a systematic clini...
IWO Meeting 16 November 2022 - Tumor-induced osteomalacia: a systematic clini...
 
IWO Meeting 16 November 2022 - Real world data: denosumab
IWO Meeting 16 November 2022 - Real world data: denosumabIWO Meeting 16 November 2022 - Real world data: denosumab
IWO Meeting 16 November 2022 - Real world data: denosumab
 
IWO Meeting 16 November 2022 - ASBMR young talent: Silvia Storoni (Amsterdam)...
IWO Meeting 16 November 2022 - ASBMR young talent: Silvia Storoni (Amsterdam)...IWO Meeting 16 November 2022 - ASBMR young talent: Silvia Storoni (Amsterdam)...
IWO Meeting 16 November 2022 - ASBMR young talent: Silvia Storoni (Amsterdam)...
 
16 November 2022 - Valevents en FLS
16 November 2022 - Valevents en FLS16 November 2022 - Valevents en FLS
16 November 2022 - Valevents en FLS
 
IWO Meeting 17 November 2021 - Prof. Dr. Joop van den Bergh
IWO Meeting 17 November 2021 - Prof. Dr. Joop van den BerghIWO Meeting 17 November 2021 - Prof. Dr. Joop van den Bergh
IWO Meeting 17 November 2021 - Prof. Dr. Joop van den Bergh
 
IWO Meeting 17 November 2021 - Prof. Dr. Willem F Lems
IWO Meeting 17 November 2021 - Prof. Dr. Willem F LemsIWO Meeting 17 November 2021 - Prof. Dr. Willem F Lems
IWO Meeting 17 November 2021 - Prof. Dr. Willem F Lems
 
IWO Meeting 17 November 2021 - Luc Maartens
IWO Meeting 17 November 2021 - Luc MaartensIWO Meeting 17 November 2021 - Luc Maartens
IWO Meeting 17 November 2021 - Luc Maartens
 
IWO Meeting 17 November 2021 - Marsha van Oostwaard
IWO Meeting 17 November 2021 - Marsha van OostwaardIWO Meeting 17 November 2021 - Marsha van Oostwaard
IWO Meeting 17 November 2021 - Marsha van Oostwaard
 
IWO Meeting 13 april 2022 - Prof. Dr. Joop van den Bergh
IWO Meeting 13 april 2022 - Prof. Dr. Joop van den BerghIWO Meeting 13 april 2022 - Prof. Dr. Joop van den Bergh
IWO Meeting 13 april 2022 - Prof. Dr. Joop van den Bergh
 
IWO Meeting 13 april 2022 - Dr. Hanna Willems
IWO Meeting 13 april 2022 - Dr. Hanna WillemsIWO Meeting 13 april 2022 - Dr. Hanna Willems
IWO Meeting 13 april 2022 - Dr. Hanna Willems
 
IWO Meeting 13 april 2022 - Prof. Dr. Piet Geusens
IWO Meeting 13 april 2022 - Prof. Dr. Piet GeusensIWO Meeting 13 april 2022 - Prof. Dr. Piet Geusens
IWO Meeting 13 april 2022 - Prof. Dr. Piet Geusens
 
IWO Meeting 13 april 2022 - Prof. Kassim Javaid
IWO Meeting 13 april 2022 - Prof. Kassim JavaidIWO Meeting 13 april 2022 - Prof. Kassim Javaid
IWO Meeting 13 april 2022 - Prof. Kassim Javaid
 

Seminair 28-04-2015 Dr. O.J. de Vries

  • 2. Valpreventie Introduction §  30 % of all people 65 and older fall ≥ once/year §  15 % falls ≥ twice/year. §  10% leads to injuries §  5 % leads to fractures: 1-2% hip fracture §  Big impact on quality of life. §  24% of 55 yr and over dies within a year following a hip fracture D r.O .J.de Vries
  • 4. Valpreventie Increased fall risk §  Risk factors: §  Age §  Dementia §  Diminished visual acuity §  Low body weight §  Gait disorder §  Prior fall §  ≥ 4 generic drugs §  Psychofarmacologicaly active drugs §  Orthostatic hypotension §  Interaction intrinsic/extrinsic factors D r.O .J.de Vries
  • 5. Valpreventie Increased fall risk §  Risk factors: §  Age §  Dementia §  Diminished visual acuity §  Low body weight §  Gait disorder §  Prior fall §  ≥ 4 generic drugs §  Psychofarmacologicaly active drugs §  Orthostatic hypotension §  Interaction intrinsic/extrinsic factors D r.O .J.de Vries
  • 6. Valpreventie Longitudinal Aging Study Amsterdam §  1992: inclusion of 3107 participants 65 yr and older in and around Zwolle, Oss and Amsterdam §  1995/1996: medical interview of 1509 participants §  Fall registration during 3 years D r.O .J.de Vries
  • 7. Valpreventie Benzodiazepines §  Screening-instrument (STOPP): §  Especially avoid long-acting benzodiazepines (half-life ≥ 24h) because of increased fall risk. D r.O .J.de Vries
  • 8. Valpreventie STOPP criteria Gallagher et al, Age and Ageing 2008; 37: 673-9 D r.O .J.de Vries
  • 9. Valpreventie STOPP criteria Gallagher et al, Age and Ageing 2008; 37: 673-9 D r.O .J.de Vries
  • 10. Valpreventie Benzodiazepines §  Screening-instrument (STOPP): §  Especially avoid long-acting benzodiazepines (half-life ≥ 24h) because of increased fall risk. §  Hypothese: §  Short-acting benzodiazepines (T1/2 ≤ 10h) are also associated with an increased fall risk. D r.O .J.de Vries
  • 11. Valpreventie Benzodiazepines §  Screening-instrument (STOPP): §  Especially avoid long-acting benzodiazepines (half-life ≥ 24h) because of increased fall risk. §  Hypothese: §  Short-acting benzodiazepines (T1/2 ≤ 10h) are also associated with an increased fall risk. §  Result: §  Short-acting benzodiazepines are associated with an increased fall risk. De Vries, O.J. et al. Age and Ageing 2013;0:1-7 D r.O .J.de Vries
  • 12. Valpreventie Antacids §  Literature: §  Protonpump inhibitor use is associated with increased fracture incidence. §  Hypothesis: §  PPI use is associated with more falls and fractures than other antacids §  Results: §  PPI use is not associated with increased fall incidence §  H2-blocker is associated with increased fall incidence. D r.O .J.de Vries
  • 13. Valpreventie Frailty §  Literature: §  Physical frailty is associated with increased fall risk §  Hypothesis: §  Frailty according to LASA is also associated with increased fall risk. §  Result: §  Frailty according to LASA is associated with increased fall risk. §  Prior falls are at least as predictive. De Vries O.J. et al. Osteoporosis International 2013; 24:2397-403 D r.O .J.de Vries
  • 14. Valpreventie Robinovitch S.N. et al. Lancet 2013;381:47-54 D r.O .J.de Vries
  • 15. Valpreventie Video capture of the circumstances of falls in elderly people residing in long-term care: an observational study. §  227 falls of 130 persons (mean age 78 yr, SD 10) §  Activities during fall: §  Walking forward 24% §  Standing 13% §  Sitting down 12% §  Start walking 9% §  Rising from a chair 9% §  Cause of fall: §  Weight shifting 41% §  Trip or stumble 21% §  Hit or bump 11% §  Loss of support 11% §  Collapse 11% §  Slipping 3% Robinovitch et al. Lancet 2013;381:47-54. D r.O .J.de Vries
  • 17. Valpreventie CBO guideline (2004) “Prevention of falls in older persons” D r.O .J.de Vries
  • 18. Valpreventie The CBO fall guideline recommends: §  Medication evaluation §  Balance and strength training §  Restore visual acuity §  Safety in and around home §  Estimate fracture risk §  Consider evaluation of heart rhythm disorders §  Possibly the highest risk reduction can be achieved in high risk older persons. D r.O .J.de Vries
  • 19. Valpreventie Multifactorial fall prevention study §  Hypothesis: §  Multifactorial analysis and intervention in older persons with increased fall risk leads to prevention of new falls. §  Method: §  217 older persons in and around Amsterdam §  Recent fall (ED or general practitioner) §  Intervention and control group(106 vs 111) §  1 year fall follow-up (calendar) §  After 1 year measurement of QoL, mobility and mood. D r.O .J.de Vries
  • 20. Valpreventie Multifactorial fall prevention study §  Results: §  No difference between intervention and control group in time to first fall. §  In both groups decrease of the number of falls. §  No differences in secondary outcomes apart from mortality. §  Discussion: §  A lot of interventions in the control group. §  Most potential participants refused: selection of the most motivated. §  The type of physical therapy possibly led to increased fall risk. D r.O .J.de Vries
  • 21. Valpreventie Medication reduction fall prevention §  Hypothesis: §  Stopping or reducing fall-risk-increasing drugs in high risk older persons leads to prevention of new falls. §  Method: §  612 older persons in and around Rotterdam and Amsterdam §  Recent fall (ED) §  Intervention and control group (319 vs 293) §  1 year registration of falls, GP and ED visits. §  After 1 year measurement of QoL. D r.O .J.de Vries
  • 22. Valpreventie Medication reduction fall prevention §  Results: §  No difference in time to 1st or 2nd fall nor in number of falls. §  40% of the FRIDs were necessary. §  36% of the medication reduction interventions failed. §  Discussion: §  ≥50% of the FRIDs were not discontinued; compliance, dependence, necessity? §  Possibly better effect with long-term physician-patient relation. D r.O .J.de Vries
  • 23. Valpreventie Meta-analysis §  Gillespie LD, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev. 2012 §  159 trials with 79,193 community dwelling participants §  Results: §  Physical therapy or tai-chi: reduces both fall risk and fall rate. §  Multifactorial fall prevention: reduces only fall rate. D r.O .J.de Vries
  • 24. Valpreventie Future §  Studies of the relation between risk factors and effectivity of different interventions. §  Studies of more effective fall prevention: medication, physical therapy, reduction of fear of falls, etc. §  Clinically relevant and irrespective of dogmas D r.O .J.de Vries